HL

Hong Liu

ET Eureka Therapeutics: 4 patents #1 of 15Top 7%
MC Memorial Sloan Kettering Cancer Center: 1 patents #35 of 158Top 25%
Merck: 1 patents #220 of 712Top 35%
📍 Beijing, ME: #1 of 2 inventorsTop 50%
Overall (2022): #31,946 of 548,613Top 6%
5
Patents 2022

Issued Patents 2022

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
11447564 Constructs specifically recognizing glypican 3 and uses thereof Pengbo Zhang, Yiyang Xu, Javier Morales, Yoko Nakano, Jingyi Xiang +1 more 2022-09-20
11421013 Antibody/T-cell receptor chimeric constructs and uses thereof Jingwei Lu, Zhiyuan Yang, Cheng Liu, Yiyang Xu, Su Yan +2 more 2022-08-23
11384144 T cell receptor-like antibodies specific for a PRAME peptide David A. Scheinberg, Tao Dao, Cheng Liu, Yiyang Xu, Su Yan 2022-07-12
11377438 2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors Ashok Arasappan, Ian M. Bell, Michael J. Breslin, Christopher James Bungard, Christopher S. Burgey +11 more 2022-07-05
11274157 Constructs targeting histone H3 peptide/MHC complexes and uses thereof Vivien Chan, Yoko Nakano, Yiyang Xu 2022-03-15